European Parliament to investigate Pharma influence on WHO 'falsified flu pandemic'

5 January 2010

Member states of the Council of Europe are set to launch an emergency debate and inquiry this month on the influence of pharmaceutical companies on the global swine flu campaign, focusing especially on the extent to which the industry influenced the World Health Organization regarding this issue, according to an article by F William Engdahl writing in Global Research

The Health Committee of the European Union Parliament has unanimously passed a resolution calling for the inquiry. The step is a long-overdue move to public transparency of a 'Golden Triangle' of drug corruption between the WHO, the pharma industry and academic scientists that has permanently damaged the lives of millions and even caused death, said Mr Engdahl.

The parliament motion was introduced by Wolfgang Wodarg, a former SPD Member of the German Bundestag (Parliament) and now chairman of the Health Committee of the Parliamentary Assembly of the Council of Europe (PACE). Dr Wodarg is a medical doctor and epidemiologist, a specialist in lung disease and environmental medicine, who considers the current 'pandemic' Swine Flu campaign of the WHO to be 'one of the greatest medicine scandals of the Century.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical